66631-29-6,MFCD00443919
Catalog No.:AA00FCW9

66631-29-6 | 4-(1H-Benzo[d]imidazol-2-yl)benzoic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
90%
in stock  
$150.00   $105.00
- +
250mg
90%
in stock  
$279.00   $195.00
- +
1g
90%
in stock  
$579.00   $405.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00FCW9
Chemical Name:
4-(1H-Benzo[d]imidazol-2-yl)benzoic acid
CAS Number:
66631-29-6
Molecular Formula:
C14H10N2O2
Molecular Weight:
238.2414
MDL Number:
MFCD00443919
SMILES:
OC(=O)c1ccc(cc1)c1nc2c([nH]1)cccc2
Properties
Properties
 
Storage:
Room Temperature;Keep in dry area;  

Computed Properties
 
Complexity:
313  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2.8  

Downstream Synthesis Route

[1]Senapak,Warapong;Saeeng,Rungnapha;Jaratjaroonphong,Jaray;Promarak,Vinich;Sirion,Uthaiwan[Tetrahedron,2019,vol.75,#26,p.3543-3552]

[2]Kasprzak,Artur;Bystrzejewski,Michał;Poplawska,Magdalena[DaltonTransactions,2018,vol.47,#18,p.6314-6322]

[3]Yadav,Priyanka;Kakati,Praachi;Singh,Preeti;Awasthi,SatishK.[AppliedCatalysisA:General,2021,vol.612]

[4]Digwal,ChanderSingh;Yadav,Upasana;Sakla,AkashP.;SriRamya;Aaghaz,Shams;Kamal,Ahmed[TetrahedronLetters,2016,vol.57,#36,p.4012-4016]

[5]Xu,Yong-Jiang;Miao,Hua-Quan;Pan,Weitao;Navarro,ElizabethC.;Tonra,JamesR.;Mitelman,Stan;Camara,M.Margarita;Deevi,DhanvanthriS.;Kiselyov,AlexanderS.;Kussie,Paul;Wong,WaiC.;Liu,Hu[BioorganicandMedicinalChemistryLetters,2006,vol.16,#2,p.404-408]

[6]CurrentPatentAssignee:HANHAIXINTUOHANGZHOUBIOMEDICAL-CN111793066,2020,ALocationinpatent:Paragraph0402-0405

[7]CurrentPatentAssignee:ELILILLY&CO-WO2005/30206,2005,A1Locationinpatent:Page/Pagecolumn64

[8]Simonis[ChemischeBerichte,1912,vol.45,p.1586]

[9]Sun,Qun;Yan,Bing[BioorganicandMedicinalChemistryLetters,1998,vol.8,#4,p.361-364]

[10]Pan,Weitao;Miao,Hua-Quan;Xu,Yong-Jiang;Navarro,ElizabethC.;Tonra,JamesR.;Corcoran,Erik;Lahiji,Armin;Kussie,Paul;Kiselyov,AlexanderS.;Wong,WaiC.;Liu,Hu[BioorganicandMedicinalChemistryLetters,2006,vol.16,#2,p.409-412]

[11]Locationinpatent:experimentalpartKus,Canan;Soezuedoenmez,Fatma;Altanlar,Nurten[ArchivderPharmazie,2009,vol.342,#1,p.54-60]

19056-41-8    66631-29-6   
4-(1<i>H</i>-benzoimidazol-2-yl)-<i>N</i>-(3-bromo-4-methoxy-phenyl)-benzamide 

[1]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.404-408

2963-77-1    66631-29-6   
9,4-(1H-benzoimidazol-2-yl)-N-4-(1H-benzoimidazol-2-yl)-phenyl-benzamide 

[1]Patent:WO2005/30206,2005,A1.Locationinpatent:Page/Pagecolumn64

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: 4-(1H-Benzimidazol-3-ium-2-yl)benzoate dihydrate.

Journal: Acta crystallographica. Section C, Crystal structure communications 20010201

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Historical Records
Tags:66631-29-6 Molecular Formula|66631-29-6 MDL|66631-29-6 SMILES|66631-29-6 4-(1H-Benzo[d]imidazol-2-yl)benzoic acid
Catalog No.: AA00FCW9
66631-29-6,MFCD00443919
66631-29-6 | 4-(1H-Benzo[d]imidazol-2-yl)benzoic acid
Pack Size: 100mg
Purity: 90%
in stock
$150.00 $105.00
Pack Size: 250mg
Purity: 90%
in stock
$279.00 $195.00
Pack Size: 1g
Purity: 90%
in stock
$579.00 $405.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00FCW9
Chemical Name: 4-(1H-Benzo[d]imidazol-2-yl)benzoic acid
CAS Number: 66631-29-6
Molecular Formula: C14H10N2O2
Molecular Weight: 238.2414
MDL Number: MFCD00443919
SMILES: OC(=O)c1ccc(cc1)c1nc2c([nH]1)cccc2
Properties
Storage: Room Temperature;Keep in dry area;  
Complexity: 313  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 18  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2.8  
Downstream Synthesis Route
619-66-9    95-54-5    66631-29-6 

[1]Senapak,Warapong;Saeeng,Rungnapha;Jaratjaroonphong,Jaray;Promarak,Vinich;Sirion,Uthaiwan[Tetrahedron,2019,vol.75,#26,p.3543-3552]

[2]Kasprzak,Artur;Bystrzejewski,Michał;Poplawska,Magdalena[DaltonTransactions,2018,vol.47,#18,p.6314-6322]

[3]Yadav,Priyanka;Kakati,Praachi;Singh,Preeti;Awasthi,SatishK.[AppliedCatalysisA:General,2021,vol.612]

[4]Digwal,ChanderSingh;Yadav,Upasana;Sakla,AkashP.;SriRamya;Aaghaz,Shams;Kamal,Ahmed[TetrahedronLetters,2016,vol.57,#36,p.4012-4016]

[5]Xu,Yong-Jiang;Miao,Hua-Quan;Pan,Weitao;Navarro,ElizabethC.;Tonra,JamesR.;Mitelman,Stan;Camara,M.Margarita;Deevi,DhanvanthriS.;Kiselyov,AlexanderS.;Kussie,Paul;Wong,WaiC.;Liu,Hu[BioorganicandMedicinalChemistryLetters,2006,vol.16,#2,p.404-408]

[6]CurrentPatentAssignee:HANHAIXINTUOHANGZHOUBIOMEDICAL-CN111793066,2020,ALocationinpatent:Paragraph0402-0405

[7]CurrentPatentAssignee:ELILILLY&CO-WO2005/30206,2005,A1Locationinpatent:Page/Pagecolumn64

[8]Simonis[ChemischeBerichte,1912,vol.45,p.1586]

[9]Sun,Qun;Yan,Bing[BioorganicandMedicinalChemistryLetters,1998,vol.8,#4,p.361-364]

[10]Pan,Weitao;Miao,Hua-Quan;Xu,Yong-Jiang;Navarro,ElizabethC.;Tonra,JamesR.;Corcoran,Erik;Lahiji,Armin;Kussie,Paul;Kiselyov,AlexanderS.;Wong,WaiC.;Liu,Hu[BioorganicandMedicinalChemistryLetters,2006,vol.16,#2,p.409-412]

[11]Locationinpatent:experimentalpartKus,Canan;Soezuedoenmez,Fatma;Altanlar,Nurten[ArchivderPharmazie,2009,vol.342,#1,p.54-60]

19056-41-8    66631-29-6   
4-(1<i>H</i>-benzoimidazol-2-yl)-<i>N</i>-(3-bromo-4-methoxy-phenyl)-benzamide 

[1]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.404-408

2963-77-1    66631-29-6   
9,4-(1H-benzoimidazol-2-yl)-N-4-(1H-benzoimidazol-2-yl)-phenyl-benzamide 

[1]Patent:WO2005/30206,2005,A1.Locationinpatent:Page/Pagecolumn64

Literature fold

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: 4-(1H-Benzimidazol-3-ium-2-yl)benzoate dihydrate.

Journal: Acta crystallographica. Section C, Crystal structure communications20010201

Building Blocks More >
67686-05-9
67686-05-9
Ethyl 2-(1-methylpiperidin-4-yl)acetate
AA00FD15 | MFCD11100758
691394-24-8
691394-24-8
PIPERAZIN-1-YL-O-TOLYL-METHANONE HYDROCHLORIDE
AA00FD5U | MFCD08444058
65947-37-7
65947-37-7
.beta.-D-Glucopyranoside, 2-propenyl 2-(acetylamino)-2-deoxy-4,6-O-(phenylmethylene)-
AA00FDB3 | MFCD15144923
719300-59-1
719300-59-1
1-(ChloroMethyl)-1-Methyl-4-(2-Methyl-10H-thieno[2,3-b][1,5]benzodiazepin-4-yl)-piperaziniuM Chloride
AA00FDKN | MFCD27967084
65730-02-1
65730-02-1
2-Propenyl 2-(Acetylamino)-2-deoxy-3,6-bis-O-(phenylmethyl)--D-glucopyranoside
AA00FDS9 | MFCD15144922
70170-91-1
70170-91-1
3-(4-Formylphenoxy)propanoic acid
AA00FE13 | MFCD10009898
676525-77-2
676525-77-2
(4,4'-Di-tert-butyl-2,2'-bipyridine)bis[(2-pyridinyl)phenyl]iridium(iii) hexafluorophosphate
AA00FEGK | MFCD27952560
68634-02-6
68634-02-6
Methyl 1-oxo-2,3-dihydro-1h-indene-5-carboxylate
AA00FF9E | MFCD09263429
685853-35-4
685853-35-4
2-(4-BROMO-2-ISOPROPYLPHENOXY)ACETIC ACID
AA00FFMO | MFCD03847928
69371-75-1
69371-75-1
2-Ethoxyethanesulfonyl chloride
AA00FFXB | MFCD10032392
Submit
© 2017 AA BLOCKS, INC. All rights reserved.